• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec9
Federal Pharmaceutical Subsidiary's Two Eye Drops Approved for Market by National Drug Administration
10:02
Federal Pharmaceutical Obtains Approval for Moxifloxacin Hydrochloride Eye Drops
09:59
Nov26
Fed Pharma Zhongshan Branch's Cefoperazone Sodium and Sulbactam Sodium for Injection Passes Consistency Evaluation
09:12
Sep30
Federation Pharma's Innovative Drug UBT37034 Receives Clinical Trial Approval from National Medical Products Administration
08:38
Sep19
Zhongtai Securities Gives 'Buy' Rating to Fed Pharma
06:03
Sep17
CITIC Securities Initiates Coverage of FedPharma with a Strong Buy Rating
06:39

Schedules & Filings

Schedules
Filings
Oct15
Distribution Plan(CST)

Cash dividend 0.175 HKD

Sep26
Distribution Plan(CST)

Cash dividend 0.175 HKD

Sep25
Distribution Plan(CST)

Cash dividend 0.175 HKD

View More

Stock List

Top Gainers
Top Decliners
Main Board
Symbol
Price
%Chg
Change
08375
2.200
+78.86%
+0.970
08186
1.260
+70.27%
+0.520
08111
0.112
+64.71%
+0.044
08026
0.495
+41.43%
+0.145
00685
0.270
+35.00%
+0.070
02668
0.174
+34.88%
+0.045
08208
0.083
+33.87%
+0.021
01825
0.123
+32.26%
+0.030
02563
4.250
+28.79%
+0.950
08042
0.068
+25.93%
+0.014
View More